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Background
Trypanosoma brucei (T. brucei) is a single celled parasite,
subspecies of which are causative agents of African sleep-
ing sickness in humans and nagana in domestic animals.
Sleeping sickness is endemic in about 36 countries in Sub-
Saharan Africa and is threatening over 60 million people.
Disease prevention is a priority, as few effective drugs are
available. Currently, there are only four drugs used as
treatment: Pentamidine, Suramin. Melarsoprol and Eflor-
nithine, though they have poor safety profiles, challeng-
ing treatment regimes and lack in efficacy. There is
therefore a great need in identifying novel therapeutics for
the treatment of sleeping sickness and fortunately, efforts
have intensified over recent years. One such development
has been the availability of the Pathway Tools Software
[1]. We have used this production software to set up
TrypanoCyc, a metabolic pathway database for T. brucei
http://www.genedb.org/tmp/.
Methods/results
Based on the available genome annotation, Pathologic
assigned proteins to reactions and pathways. The Pathway
hole filler algorithm was subsequently used to identify
missing enzyme annotations in the T. brucei genome. Fur-
ther manual refinement included enzymes and pathways
previously identified in the literature but unique to T. bru-
cei (e.g. GPI Biosynthetic pathway) and thus not present
as 'generic' pathways in the tool. A total of 178 pathways
were identified comprising 1112 enzymes, 341 of which
represented additional annotations to proteins with no
previous functional assignments.
In order to determine potential drug targets, we per-
formed chokepoint analyses of the metabolic network of
T. brucei. We define a "chokepoint reaction" as a reaction
that either uniquely consumes a specific substrate or
uniquely produces a specific product in the TrypanoCyc
metabolic network. We expect the inhibition of an
enzyme that consumes a unique substrate to result in the
accumulation of the unique substrate (potentially toxic to
the cell) and the inhibition of an enzyme that produces a
unique product to result in the starvation of the unique
product (potentially crippling essential cell functions).
168 enzymes were identified as choke point enzymes and
this set included almost all of the drug targets of currently
used and proposed drugs (e.g. trypanothione pathway –
Figure 1) against sleeping sickness.
Conclusion
TrypanoCyc, a database of metabolic pathways for T. bru-
cei will remain an invaluable resource for detailed analy-
ses of the metabolic network of the parasite T. brucei and
related species. The database will continually be updated
with new reactions and pathways identified from Litera-
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ture and refinement of chokepoint analyses to identify
potential drug targets would be a priority.
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A graphical overview of TrypanoCycFi ure 1
A graphical overview of TrypanoCyc: Trypanothione pathway (coloured green) and biopterin pathway (coloured red) in 
graphical overview diagram of TrypanoCyc.Page 2 of 2
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